0001236030-24-000007.txt : 20240423 0001236030-24-000007.hdr.sgml : 20240423 20240423170655 ACCESSION NUMBER: 0001236030-24-000007 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240419 FILED AS OF DATE: 20240423 DATE AS OF CHANGE: 20240423 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KERSTEN GEERT R CENTRAL INDEX KEY: 0001236030 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11889 FILM NUMBER: 24865661 MAIL ADDRESS: STREET 1: 8229 BOONE BLVD STREET 2: STE 802 CITY: VIENNA STATE: VA ZIP: 22182 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CEL SCI CORP CENTRAL INDEX KEY: 0000725363 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 840916344 STATE OF INCORPORATION: CO FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 8229 BOONE BLVD . STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 BUSINESS PHONE: 7035069460 MAIL ADDRESS: STREET 1: 8229 BOONE BLVD. STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 FORMER COMPANY: FORMER CONFORMED NAME: INTERLEUKIN 2 INC DATE OF NAME CHANGE: 19880317 4 1 primary_doc.xml PRIMARY DOCUMENT X0508 4 2024-04-19 0 0000725363 CEL SCI CORP CVM 0001236030 KERSTEN GEERT R 8229 BOONE BLVD STE 802 VIENNA VA 22182 1 1 0 0 Chief Executive Officer 0 Options 1.5 2024-04-19 4 A 0 250000 0.01 A 2034-04-18 Common Stock 250000 4504709 D The stock options vest in three (3) equal annual installments commencing one year after the grant date. Geert Kersten 2024-04-23